Literature DB >> 24833705

Inducible loss of one Apc allele in Lrig1-expressing progenitor cells results in multiple distal colonic tumors with features of familial adenomatous polyposis.

Anne E Powell1, Gregory Vlacich2, Zhen-Yang Zhao3, Eliot T McKinley1, M Kay Washington4, H Charles Manning5, Robert J Coffey6.   

Abstract

Individuals with familial adenomatous polyposis (FAP) harbor a germline mutation in adenomatous polyposis coli (APC). The major clinical manifestation is development of multiple colonic tumors at a young age due to stochastic loss of the remaining APC allele. Extracolonic features, including periampullary tumors, gastric abnormalities, and congenital hypertrophy of the retinal pigment epithelium, may occur. The objective of this study was to develop a mouse model that simulates these features of FAP. We combined our Lrig1-CreERT2/+ mice with Apcfl/+ mice, eliminated one copy of Apc in leucine-rich repeats and immunoglobulin-like domains protein 1 (Lrig1)-positive (Lrig1(+)) progenitor cells with tamoxifen injection, and monitored tumor formation in the colon by colonoscopy and PET. Initial loss of one Apc allele in Lrig1(+) cells results in a predictable pattern of preneoplastic changes, culminating in multiple distal colonic tumors within 50 days of induction, as well as the extracolonic manifestations of FAP mentioned above. We show that tumor formation can be monitored by noninvasive PET imaging. This inducible stem cell-driven model recapitulates features of FAP and offers a tractable platform on which therapeutic interventions can be monitored over time by colonoscopy and noninvasive imaging.
Copyright © 2014 the American Physiological Society.

Entities:  

Keywords:  colorectal cancer; mouse models; stem cells

Mesh:

Substances:

Year:  2014        PMID: 24833705      PMCID: PMC4080164          DOI: 10.1152/ajpgi.00358.2013

Source DB:  PubMed          Journal:  Am J Physiol Gastrointest Liver Physiol        ISSN: 0193-1857            Impact factor:   4.052


  29 in total

1.  Long-lived intestinal tuft cells serve as colon cancer-initiating cells.

Authors:  C Benedikt Westphalen; Samuel Asfaha; Yoku Hayakawa; Yoshihiro Takemoto; Dana J Lukin; Andreas H Nuber; Anna Brandtner; Wanda Setlik; Helen Remotti; Ashlesha Muley; Xiaowei Chen; Randal May; Courtney W Houchen; James G Fox; Michael D Gershon; Michael Quante; Timothy C Wang
Journal:  J Clin Invest       Date:  2014-03       Impact factor: 14.808

2.  Importance of epidermal growth factor receptor signaling in establishment of adenomas and maintenance of carcinomas during intestinal tumorigenesis.

Authors:  Reade B Roberts; Lu Min; M Kay Washington; Sandra J Olsen; Stephen H Settle; Robert J Coffey; David W Threadgill
Journal:  Proc Natl Acad Sci U S A       Date:  2002-01-29       Impact factor: 11.205

Review 3.  Understanding phenotypic variation in rodent models with germline Apc mutations.

Authors:  Maged Zeineldin; Kristi L Neufeld
Journal:  Cancer Res       Date:  2013-04-11       Impact factor: 12.701

4.  Synthesis and structure-activity relationships of 5,6,7-substituted pyrazolopyrimidines: discovery of a novel TSPO PET ligand for cancer imaging.

Authors:  Dewei Tang; Eliot T McKinley; Matthew R Hight; Md Imam Uddin; Joel M Harp; Allie Fu; Michael L Nickels; Jason R Buck; H Charles Manning
Journal:  J Med Chem       Date:  2013-04-03       Impact factor: 7.446

Review 5.  More than two decades of Apc modeling in rodents.

Authors:  Maged Zeineldin; Kristi L Neufeld
Journal:  Biochim Biophys Acta       Date:  2013-01-17

6.  Sox9 induction, ectopic Paneth cells, and mitotic spindle axis defects in mouse colon adenomatous epithelium arising from conditional biallelic Apc inactivation.

Authors:  Ying Feng; Kazuhiro Sentani; Alexandra Wiese; Evan Sands; Maranne Green; Guido T Bommer; Kathleen R Cho; Eric R Fearon
Journal:  Am J Pathol       Date:  2013-06-13       Impact factor: 4.307

7.  Lineage tracing reveals Lgr5+ stem cell activity in mouse intestinal adenomas.

Authors:  Arnout G Schepers; Hugo J Snippert; Daniel E Stange; Maaike van den Born; Johan H van Es; Marc van de Wetering; Hans Clevers
Journal:  Science       Date:  2012-08-01       Impact factor: 47.728

8.  Defining the mode of tumour growth by clonal analysis.

Authors:  Gregory Driessens; Benjamin Beck; Amélie Caauwe; Benjamin D Simons; Cédric Blanpain
Journal:  Nature       Date:  2012-08-23       Impact factor: 49.962

9.  Comprehensive molecular characterization of human colon and rectal cancer.

Authors: 
Journal:  Nature       Date:  2012-07-18       Impact factor: 49.962

Review 10.  LRIG1 is a triple threat: ERBB negative regulator, intestinal stem cell marker and tumour suppressor.

Authors:  Y Wang; E J Poulin; R J Coffey
Journal:  Br J Cancer       Date:  2013-04-04       Impact factor: 7.640

View more
  33 in total

1.  Multiscale analysis of the murine intestine for modeling human diseases.

Authors:  Jesse Lyons; Charles A Herring; Amrita Banerjee; Alan J Simmons; Ken S Lau
Journal:  Integr Biol (Camb)       Date:  2015-07       Impact factor: 2.192

2.  Targeted mobilization of Lrig1+ gastric epithelial stem cell populations by a carcinogenic Helicobacter pylori type IV secretion system.

Authors:  Lydia E Wroblewski; Eunyoung Choi; Christine Petersen; Alberto G Delgado; M Blanca Piazuelo; Judith Romero-Gallo; Tyler L Lantz; Yana Zavros; Robert J Coffey; James R Goldenring; Anne E Zemper; Richard M Peek
Journal:  Proc Natl Acad Sci U S A       Date:  2019-09-05       Impact factor: 11.205

Review 3.  The LRIG family: enigmatic regulators of growth factor receptor signaling.

Authors:  Catalina Simion; Maria Elvira Cedano-Prieto; Colleen Sweeney
Journal:  Endocr Relat Cancer       Date:  2014-09-02       Impact factor: 5.678

4.  KLF9 and JNK3 Interact to Suppress Axon Regeneration in the Adult CNS.

Authors:  Akintomide Apara; Joana Galvao; Yan Wang; Murray Blackmore; Allison Trillo; Keiichiro Iwao; Dale P Brown; Kimberly A Fernandes; Abigail Huang; Tu Nguyen; Masoumeh Ashouri; Xiong Zhang; Peter X Shaw; Noelia J Kunzevitzky; Darcie L Moore; Richard T Libby; Jeffrey L Goldberg
Journal:  J Neurosci       Date:  2017-09-04       Impact factor: 6.167

5.  A Chimeric Egfr Protein Reporter Mouse Reveals Egfr Localization and Trafficking In Vivo.

Authors:  Yu-Ping Yang; Haiting Ma; Alina Starchenko; Won Jae Huh; Wei Li; F Edward Hickman; Qin Zhang; Jeffrey L Franklin; Douglas P Mortlock; Sabine Fuhrmann; Bruce D Carter; Rebecca A Ihrie; Robert J Coffey
Journal:  Cell Rep       Date:  2017-05-09       Impact factor: 9.423

6.  Regulation of Tumor Initiation by the Mitochondrial Pyruvate Carrier.

Authors:  Claire L Bensard; Dona R Wisidagama; Kristofor A Olson; Jordan A Berg; Nathan M Krah; John C Schell; Sara M Nowinski; Sarah Fogarty; Alex J Bott; Peng Wei; Katja K Dove; Jason M Tanner; Vanja Panic; Ahmad Cluntun; Sandra Lettlova; Christian S Earl; David F Namnath; Karina Vázquez-Arreguín; Claudio J Villanueva; Dean Tantin; L Charles Murtaugh; Kimberley J Evason; Gregory S Ducker; Carl S Thummel; Jared Rutter
Journal:  Cell Metab       Date:  2019-12-05       Impact factor: 27.287

7.  [18F]FEPPA: Improved Automated Radiosynthesis, Binding Affinity, and Preliminary in Vitro Evaluation in Colorectal Cancer.

Authors:  Neydher Berroterán-Infante; Theresa Balber; Petra Fürlinger; Michael Bergmann; Rupert Lanzenberger; Marcus Hacker; Markus Mitterhauser; Wolfgang Wadsak
Journal:  ACS Med Chem Lett       Date:  2018-02-21       Impact factor: 4.345

8.  TSPO-targeted PET and Optical Probes for the Detection and Localization of Premalignant and Malignant Pancreatic Lesions.

Authors:  Allison S Cohen; Jun Li; Matthew R Hight; Eliot McKinley; Allie Fu; Adria Payne; Yang Liu; Dawei Zhang; Qing Xie; Mingfeng Bai; Gregory D Ayers; Mohammed Noor Tantawy; Jarrod A Smith; Frank Revetta; M Kay Washington; Chanjuan Shi; Nipun Merchant; H Charles Manning
Journal:  Clin Cancer Res       Date:  2020-09-15       Impact factor: 12.531

9.  Facile synthesis of SSR180575 and discovery of 7-chloro-N,N,5-trimethyl-4-oxo-3(6-[(18)F]fluoropyridin-2-yl)-3,5-dihydro-4H-pyridazino[4,5-b]indole-1-acetamide, a potent pyridazinoindole ligand for PET imaging of TSPO in cancer.

Authors:  Yiu-Yin Cheung; Michael L Nickels; Dewei Tang; Jason R Buck; H Charles Manning
Journal:  Bioorg Med Chem Lett       Date:  2014-08-08       Impact factor: 2.823

Review 10.  DNA methylation aberrancies delineate clinically distinct subsets of colorectal cancer and provide novel targets for epigenetic therapies.

Authors:  D J Weisenberger; G Liang; H-J Lenz
Journal:  Oncogene       Date:  2017-10-09       Impact factor: 9.867

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.